APA (7th ed.) Citation

Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., . . . Iba, T. (2020). DOACs and “newer” hemophilia therapies in COVID‐19: Reply. Journal of thrombosis and haemostasis, 18(7), 1795-1796. https://doi.org/10.1111/jth.14841

Chicago Style (17th ed.) Citation

Thachil, Jecko, Ning Tang, Satoshi Gando, Anna Falanga, Marco Cattaneo, Marcel Levi, Cary Clark, and Toshiaki Iba. "DOACs and “newer” Hemophilia Therapies in COVID‐19: Reply." Journal of Thrombosis and Haemostasis 18, no. 7 (2020): 1795-1796. https://doi.org/10.1111/jth.14841.

MLA (9th ed.) Citation

Thachil, Jecko, et al. "DOACs and “newer” Hemophilia Therapies in COVID‐19: Reply." Journal of Thrombosis and Haemostasis, vol. 18, no. 7, 2020, pp. 1795-1796, https://doi.org/10.1111/jth.14841.